The adult heart has almost completely lost the proliferative potential of the fetal heart. Instead, loss of cardiomyocytes due to myocardial infarction (MI) leads to a limited, and often insufficient, hypertrophic response of cardiomyocytes in the spared myocardium. This response is still characterized by a partial re-expression of the fetal gene program. Because of the suggested involvement of microRNAs (miRNA) in cardiac remodeling we examined the miRNA expression profile of the spared left ventricular myocardium using a MI mouse model. C57Bl/6J mice of either sex were randomly assigned to the shamoperated group or MI group. MI was induced by ligation of the left anterior descending (LAD) coronary artery. One week post-operation RNA was isolated from the left ventricle. MiRNA analysis was performed using the Taqman Megaplex rodent array. Un expectedly, we found a set of 29 upregulated miRNAs originating from the Dlk1-Dio3 genomic imprinted region, which has been identified as a hallmark of pluripotency and proliferation. This miRNA signature was associated with a six-fold increase in expression of the deiodinase type 3 gene (Dio3) located in this region. Dio3 is a fetally expressed thyroidhormone inactivating enzyme associated with cell proliferation, which was shown to be upregulated in cardiomyocytes creating a local hypothyroid condition in the spared myocardium in this model. These data suggest that a regenerative process is initiated, but not completed, in adult cardiomyocytes following MI. The identified miRNA signature could permit new ways to manipulate the in vivo response of adult cardiomyocytes to stress and to increase the regenerative capacity of the injured myocardium.
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Abstract
Myocardial infarction (MI) and the subsequent necrosis and fibrosis of the affected part of the left ventricle (LV) trigger functional and structural remodeling of the spared myocardium to reduce ventricular wall stress and to preserve cardiac output (Bernardo et al. 2010 ). The heart is considered to be an essentially postmitotic organ with only marginal regenerative capacity (Laflamme and Murry 2011) and hypertrophy of resident cardiomyocytes is the principle adaptive response to injury (Bernardo et al. 2010) . Cell growth includes changes in expression profiles of proteins involved in contraction, metabolism and ion homeostasis, and constitutes a partial re-expression of the fetal gene program. This is governed by a complex set of signal-transduction routes, with an additional level of regulation provided by recently identified non-coding transcripts such as microRNAs (miRNA) (Bernardo et al. 2010; Small, Frost, and Olson 2010; Thum et al. 2007) .
One of the developmentally important genes that is reinduced in remodeling rodent cardiomyocytes is the type III deiodinase (Dio3) (Pol et al. 2011; Simonides et al. 2008) , which converts the thyroid pro-hormone thyroxine (T4) and the active form 3,5,3'-triiodothyronine (T3) to the inactive metabolites 3,3',5'-triiodothyronine (rT3) and 3,3'-diiodothyronine (T2), respectively (Gereben et al. 2008) . Dio3 is expressed in most fetal tissues as well as in the placenta to prevent premature T3-induced differentiation and maturation (Gereben et al. 2008 ). Fetal development is therefore characterized by relatively low tissue levels of thyroid hormone. Around birth Dio3 expression is turned off in virtually every tissue and together with the sharp rise in plasma T3 levels after the first week of postnatal life, thyroid-hormone signaling increases substantially. In heart as well as skeletal muscle, this surge in T3 activity is involved in driving the fetal-to-adult switch in gene expression.
The re-expression of Dio3 in the mouse heart following MI is seen in an estimated 20% of cardiomyocytes throughout the spared, remodeling myocardium (Pol et al. 2011) . The accompanying increase in DIO3 activity is associated with a 50% reduction in both tissue T3 levels and cardiomyocyte-specific T3-dependent transcription (Pol et al. 2011) . As a first step in determining the role of reduced T3-signaling in the reported involvement of miRNAs in remodeling of injured myocardium (Small, Frost, and Olson 2010), we analyzed the LV miRNA expression profiles in the mouse MI model at one week following surgery when DIO3 activity is stably induced (Pol et al. 2011) . Unexpectedly, we found a miRNA signature in the remodeling LV that recently has been identified as a hallmark of pluripotency and proliferation.
Introduction Mouse model of myocardial infarction
A total of 12 C57Bl/6J mice (Harlan, 10-12 weeks old) of either sex were randomly assigned to the sham-operated group or MI group, weighed and anesthetized. MI was induced by ligation of the left anterior descending (LAD) coronary artery as was previously described (de Waard et al. 2007; van den Bos et al. 2005) . Briefly, under anesthesia (2.5% isoflurane in a mixture of air and O 2 ) a thoracotomy was performed at the fourth left intercostal space and the LAD was permanently ligated. The occlusion was confirmed by the slight change of color of the anterior wall of the LV downstream of the ligature. Sham-operated mice underwent the same procedure except for the occlusion of the LAD. After 1 week, echocardiography was used to establish the degree of LV remodeling and fractional shortening (%FS) was determined as a measure of contractile function. Subsequently, LV tissue from sham animals and non-infarcted, i.e., spared LV tissue from MI animals was collected, frozen in liquid nitrogen and stored at -80 °C. Animals were housed individually and all experiments complied with the Guide for Care and Use of Laboratory Animals of the National Institutes of Health (NIH Publication no. 86-23, revised 1996) and were approved by the Institutional Animal Care and Use Committees of VU University Medical Center Amsterdam.
RNA isolation
Approximately 50 mg of LV tissue was sliced in 10 μm sections using a cryostat. Total RNA was isolated using the mirVana PARIS kit (Ambion), according to the manufacturer's instruction. Total RNA dissolved in elution buffer was stored at -80 °C until analysis.
MiRNA analysis
MiRNA analysis was performed using the Taqman Megaplex rodent array (v3.0) (Applied Biosystems) by sequential steps of reverse transcription, preamplification and qPCR on a 7900 HT with TLDA arrays. Relative miRNA expression was calculated using RQ-manager v1.2 (Applied Biosystems) with the following settings: threshold 0.2, automatic baseline. DataAssist v3.0 (Applied Biosystems) was used for statistical analysis. MiRNAs with a Ct-value < 38 were included in the analysis. MammU6 and snoRNA202 were the most stable miRNAs and therefore chosen as endogenous controls. Outliers among replicates were excluded. For comparison of the delta-Ct values of the two groups, MI (target group) and sham (reference group), a two-tailed Student t-test was performed to calculate P values. MiRNA location was determined using http://www.mirbase.org/ and http://www.ensembl.org/index.html as reference. Significantly regulated miRNAs were evaluated with Ingenuity Systems pathway analysis (IPA) software (Ingenuity Systems, www.ingenuity.com).
Quantitative PCR
Expression levels of atrial natriuretic factor (Anf ), MHCα (Myh6), and MHCβ (Myh7) mRNA were determined by qPCR using specific primers and standard cycle parameters on an Applied Biosystems model 7500 (Applied Biosystems) with hypoxanthine-guanine-phosphoribosyl-transferase (Hprt) as correction factor. Taqman Gene expression assays were used to analyze expression levels of
In Situ Hybridization
The expression pattern of three representative miRNAs i.e. miRNA-370, -379 and -433 was evaluated by in situ hybridization (ISH) on 10 μm thick paraffinembedded LV tissue sections from sham and MI mice (Jørgensen et al. 2010). Sections were incubated for 15-30 minutes at 37 °C with proteinase K (5.0-7.5 μg/μl) Methods and methods before 40 nM of miRCURY-LNA microRNA Detection probe (Exiqon) was applied for 1 hour at optimized temperatures. Sections were next incubated with 1:500 anti-DIG-AP (Roche) for 1 hour at room temperature and exposed to alkaline-phosphatase substrate overnight at room temperature. Nuclear Fast Red (Vector Laboratories) was used as a counter stain before the sections were mounted with entellan.
One week post-MI LV function was assessed by echocar diography and an average 75% reduction of the fractional shortening confirmed ventricular dysfunction due to MI [Fig. 1a] . Total RNA was isolated from the noninfarcted area of the LV and cellular remodeling was indicated by a 60-fold increase in mRNA level of atrial natriuretic factor (Anf ) and an 80% reduction of the mRNA ratio of the myosin heavy chain isoforms MHCα and MHCβ [Fig. 1b and c] . Expression of these MHC isoforms is reciprocally regulated by T3 and the reduced ratio is at least in part indicative of the low T3 status of the remodeled LV (Pol et al. 2011) .
We subsequently analyzed all currently known mouse miRNAs using the Taqman Megaplex rodent array. Of the total of 641 known mouse miRNAs analyzed, 506 were successfully quantified of which 107 were significantly up-or downregulated in the remodeling LV compared to myocardium from sham-operated mice [Supplementary Table S1 ]. This set included previously identified miRNAs that characterize the post-MI response of both mouse and human myocardium (van Rooij et al. 2008) [ Supplementary  Fig. S1 ]. Unexpectedly, 29 of the 107 differentially expressed miRNAs were located in the Dlk1-Dio3 genomic imprinted region [Fig. 2a] and showed a 2 to 16 fold upregulation [Fig. 3] . This region is located on mouse distal chromosome 12F1 (human chromosome 14q32) and includes, next to the Dio3 gene, the protein coding genes Delta-like homologue 1 (Dlk1) and Retrotransposon-like gene 1 (Rtl1), as well as the non-coding RNA genes Meg3 (also known as Gtl2), Rian and Mirg. Additional clusters of miRNAs are located within the Rtl1 antisense sequence and interspersed between the genes in this region. Three of the differentially regulated miRNAs, i.e., miRNA-370, -379 and -433, were selected from across the Dlk1-Dio3 region for ISH analysis of the myocardium. The data in Figure 2b and Supplementary Figure S2 show that these representative miRNAs are expressed in cardiomyocytes in the remodeling LV and normal myocardium. Additional evaluation of the region using Ingenuity Systems pathway analysis (IPA) showed that the upregulated miRNA signature was found to be associated with a network related to 'skeletal and muscular disorders', and 'developmental disorder' (Network score 39, indicating a 10 -39 chance of this network occurring randomly). Activation of the Dlk1-Dio3 region in proliferating tumor cells and stem cells generally includes increased expression of all the genes located in this region and suggests involvement of the regulatory mechanisms that control imprinting of the entire domain (Benetatos, Voulgaris, and Vartholomatos 2012; Liu et al. 2010) . However, only the mRNA level of Dio3 increased six-fold, whereas those for Dlk1, Meg3, Rtl1, Rian and Mirg remained unchanged [Fig. 4] . [2a]
[b] Figure 2 Schematic representation of the Dlk1-Dio3 genomic imprinted region and localization of three representative miRNAs.
[a] The Dlk1-Dio3 region is located on mouse distal chromosome 12F1 (human chromosome 14q32 [sham: n = 6; MI: n = 6]. Figure 4 Expression profile of the coding and non-coding members of the Dlk1-Dio3 region. Taqman Gene Expression assays were used to determine the expression profiles of the coding and non-coding members of the Dlk1-Dio3 region. Dlk1, Meg3, Rtl1, Rian, and Mirg mRNA levels were not significantly different following MI, but Dio3 mRNA levels were increased six-fold (p = 0.036). Expression levels were normalized to sham values. Data represent the means ± SEM, with n = 6 for both groups. Statistical significance was tested using a two-tailed Student t-test and accepted at p < 0.05.
Deletion and gene-dosage studies in mice and humans have shown that both the protein-coding genes and non-coding RNAs in the Dlk1-Dio3 region are essential for normal growth and differentiation of a wide range of tissues (da Rocha et al. 2008 ). Re-activation of the Dlk1-Dio3 region has also been reported for various types of tumors and has been associated with increased proliferative activity and disease progression (Benetatos, Voulgaris, and Vartholomatos 2012) . Surprisingly, the concerted upregulation in the remodeling LV of 29 miRNAs from the Dlk1-Dio3 region shows a striking similarity to the miRNA signature recently found to reflect pluripotency in mouse embryonic stem cells, both in identity of miRNAs and direction of change (Liu et al. 2010) . Although it was suggested that in proliferating tumor cells the genes located in the Dlk1-Dio3 region are also upregulated (Benetatos, Voulgaris, and Vartholomatos 2012), the relative gene expression of the representative members of the region showed no significant difference between the sham and MI group, with marked exception of the Dio3 gene. The mechanism underlying the apparent absence of stimulation of the other genes is unclear. However, it has been shown that miRNA-127 and miRNA-136, which are both expressed by asRtl1 and which are increased in our study [Fig. 2] , may decrease Rtl1 expression through a RISC-mediated cleavage, thereby reducing net Rtl1 induction (E. Davis et al. 2005) . In contrast, the significant six-fold increase in the level of Dio3 mRNA in the remodeling LV associated with the Dlk1-Dio3 miRNA signature confirms earlier mRNA as well as protein data (Pol et al. 2011) .
These results suggest a separate mechanism governing the upregulation of miRNAs associated with pluripotency and proliferation in cardiomyocytes, together with the expression of Dio3. The induction of DIO3 activity fits with the condition of low cellular thyroid-hormone levels required for proliferation and is reminiscent of the recently described role of increased DIO3 activity in the regenerative potential of myocyte progenitor cells in injured skeletal muscle (Dentice et al. 2010 ). Although we cannot exclude that a relatively small population of cardiac progenitor cells present in the remodeling LV (Laflamme and Murry 2011) contributes to the observed changes in miRNA and Dio3 mRNA expression, the extent of the miRNA upregulation in combination with the previously reported in situ analysis of Dio3 expression in these hearts (Pol et al. 2011) indicates that the Dlk1-Dio3 region is activated in a substantial population of resident, adult cardiomyocytes. This is supported by the localization of representative miRNAs from the Dlk1-Dio3 region to cardiomyocytes in the remodeling LV using ISH analysis.
Taken together, the data suggest that a novel mechanism, shared with pluripotency and proliferation, has been triggered in these cardiomyocytes. Regeneration of damaged myocardium has been shown in several species including mice (Jopling, Boue, and Belmonte 2011; Porrello, Mahmoud, et al. 2011) , indicating that differentiated cardiomyocytes are indeed capable of a strong proliferative response. However, although the capacity for proliferation remains in a very small percentage of cardiomyocytes in adult mice (Bersell et al. 2009 ), this response to injury is essentially lost one week after birth (Porrello, Mahmoud, et al. 2011) , coinciding with the post-natal rise in plasma thyroidhormone levels. In this context results from a recent high-throughput functional screening of human miRNAs using rodent neonatal cardiomyocytes are particularly interesting (Eulalio et al. 2012) . Data from this study show that multiple of the 29 miRNAs located in the Dlk1-Dio3 region are individually capable of stimulating proliferation of these cardiomyocytes (Eulalio et al. 2012) . Although other studies have also shown upregulation of several miRNAs located in the Dlk1-Dio3 region in both human heart failure (Thum et al . MI. Apart from differences in species, strain of mice or model of heart failure used in these studies, the unique miRNA signature found in the present study may reflect a highly dynamic process of miRNA regulation during the initial period of post-MI remodeling.
In conclusion, our data indicate that the initiation, but not completion, of the regenerative process is a far more general response of resident cardiomyocytes in the stressed heart. We consider this finding clinically relevant as the gene signature identified in the Dlk1-Dio3 region involves a specific set of upregulated miRNAs which could permit new ways to recruit the existing capacity for proliferation of cardiomyocytes to increase the regenerative response of the injured myocardium.
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. Expression levels were normalized to sham values. Data represent the means ± SEM, with n = 6 for both groups. Statistical significance was tested using a two-tailed Student t-test and accepted at p < 0.05.
Figure S2
In situ hybridization of representative miRNAs following myocardial infarction. In situ hybridization analyses using miRCURY-LNA microRNA Detection probes (Exiqon) confirmed that at least three representative miRNAs were expressed in cardiomyocytes located in both sham and MI LV tissue. U6 was used as a universal positive control for all cell types, and miRNA-1 was used as a cardiomyocyte-specific positive control. Scrambled-probe (Exiqon) and a condition without probe were used as negative controls. Arrows indicate examples of positive purple/blue miRNA staining. Nuclei without miRNA co-staining are stained red/pink by Nuclear Fast Red. Scale bar represents 100 µm. 
